These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from ...lass="attribute-to-highlight medbox">substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
more
front cover © Jonathan Hyams/Save the Children
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...sites, viruses and fungi. This WHO report, produced in collaboration with Member States and other partners, provides for the first time, as accurate a picture as is presently possible of the magnitude of AMR and the current state of surveillance globally. It examines the information on AMR, in particular antibacterial resistance (ABR), at country level worldwide.
more
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including ...ighlight medbox">semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the risk of continued Ebola virus transmission. WHO has developed this document to guide health services on how to provide quality care to survivors of Ebola virus disease
more
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of... these disorders on the social and economic well-beingof individuals, families, and societies is large, growing, and underestimated
more
THELANCETID-D-16-00800 S1473-3099(16)30318-8
Health Policy Plan (2017) 32 (5): 603-612; 10 pp. 318 kB
JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, Vol. 28, No. 2, March/April 2017, 186-198
http://dx.doi.org/10.1016/j.jana.2015.09.003
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update